An observational study in Metabolic Syndrome, Obesity Hypoventilation Syndrome and Capnography, sponsored by SOS Oxygene Mediterranee. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-28.
Sponsored by SOS Oxygene Mediterranee · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 74 studies in Metabolic Syndrome with a site in France — 14 open to participants now, 17 under way, none of them phase 3. Metabolic Syndrome · France.
Among the 74 studies in Metabolic Syndrome with a site in France, this one is the 4th largest by planned enrollment of the 17 observational ones that give a count, is one of 4 that started in 2020, is one of 17 observational ones, reaches primary completion later than 3 of the 16 other live ones, and was the 57th registered.
2,117 studies on the registry are indexed under Metabolic Syndrome; 347 are open to participants now.
Browse Metabolic Syndrome studies →14 of the 74 studies in Metabolic Syndrome with a site in France are open now. Recruiting first, the newest first:
E-Scopics · Sites in France
Ages 18–80
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+ · Healthy volunteers
University Hospital, Montpellier · Sites in France
Ages 40–75 · Healthy volunteers
Central Hospital, Nancy, France · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 231 Metabolic Syndrome studies recruiting now, 68 (29%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 80 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
74 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 4 · Phase 4 4
First in 2005; this study’s year is marked. 4 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 400 is above the median of 197 across 496 observational studies indexed under Metabolic Syndrome.
Median enrollment 78 across the 57 interventional studies, 158 across the 17 observational. Of the 51 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 74 have an industry lead sponsor. The 10 most frequent:
SOS Oxygene Mediterranee is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
SOS Oxygene Mediterranee has 1 study filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
5 of the studies in Metabolic Syndrome with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06360302University Hospital, MontpellierPlasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients | 2026-11-18 |
| NCT05383092University Hospital, ToulouseAdapted Physical Activity for Children Treated With Cancer and Insulin Sensitivity | 2026-12-31 |
| NCT05237440University Hospital, LimogesChildhood Traumas in Obese Women: Association With Deregulation of the Glucocorticoid Axis and Inflammatory State. | 2027-05-13 |
| NCT07638111Hospices Civils de LyonSENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level | 2027-07 |
| NCT06460896Assistance Publique - Hôpitaux de ParisAnalysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs | 2027-09 |
Add all 5 to your calendar (.ics) → With an account.
Among the 74 studies in Metabolic Syndrome with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.
After being informed about the study and potential risks, patient agreed to participate and undergo :
a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled with a capnography during the same night.
Patients will be selected as part of their usual care, during a consultation for their respiratory and metabolic monitoring.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Capnia
Arterial pression in CO2 and transcutaneous pression in CO2
Time frame: Up to one mont after inclusion
Arterial pression in CO2
PaCO2
Time frame: At the inclusion
BMI
body mass index
Time frame: At the inclusion
Arterial pression in oxygen
PaO2
Time frame: At the inclusion
somnolence
EPWORTH questionnaire; Minimum = 0; Maximum = 24, Higher score means a worth outcome
Time frame: At the inclusion
Physical activity level
Ricci\&Gagnon questionnaire, Minimum = 9; Maximum = 45, Higher score means a worth outcome
Time frame: At the inclusion
Arterial blood bicarbonates
HCO3-
Time frame: At the inclusion
Arterial blood gases
pH
Time frame: At the inclusion
Hemoglobin
Hb
Time frame: At the inclusion
obstructive sleep apnea items
Apnea-hypopnea index
Time frame: Up to one mont after inclusion
Night Oxygen saturation
SpO2
Time frame: Up to one mont after inclusion
Started Aug 2020 (actual). Primary completion is estimated for Aug 2025, 60 months after the start.
Of 160 observational studies under Metabolic Syndrome, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 106. This study's planned 60 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SOS Oxygene Mediterranee